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Abstract
Background—Pneumonia remains a leading cause of under-five morbidity and mortality 
globally. Comprehensive incidence, epidemiologic and etiologic data are needed to update 
prevention and control strategies.
Methods—We conducted active, population-based surveillance for hospitalized cases of acute 
lower respiratory tract infections (ALRI) among children <5 years of age in rural thailand. ALRI 
cases were systematically sampled for an etiology study that tested nasopharyngeal specimens by 
polymerase chain reaction; children without ALRI were enrolled as controls from outpatient 
clinics.
Results—We identified 28,543 hospitalized ALRI cases from 2005 to 2010. Among the 49% 
with chest radiographs, 63% had findings consistent with pneumonia as identified by 2 study 
radiologists. The hospitalized ALRI incidence rate was 5772 per 100,000 child-years (95% 
confidence interval: 5707, 5837) and was higher in boys versus girls (incidence rate ratio 1.38, 
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95% confidence interval: 1.35–1.41) and in children 6–23 months of age versus other age groups 
(incidence rate ratio 1.76, 95% confidence interval: 1.69–1.84). Viruses most commonly detected 
in ALRI cases were respiratory syncytial virus (19.5%), rhinoviruses (18.7%), bocavirus (12.8%) 
and influenza viruses (8%). Compared with controls, ALRI cases were more likely to test positive 
for respiratory syncytial virus, influenza, adenovirus, human metapneumovirus and parainfluenza 
viruses 1 and 3 (P ≤ 0.01 for all). Bloodstream infections, most commonly Streptococcus 
pneumoniae and nontyphoidal Salmonella, accounted for 1.8% of cases.
Conclusions—Our findings underscore the high burden of hospitalization for ALRI and the 
importance of viral pathogens among children in Thailand. Interventions targeting viral pathogens 
coupled with improved diagnostic approaches, especially for bacteria, are critical for better 
understanding of ALRI etiology, prevention and control.
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An estimated 156 million childhood clinical pneumonia cases occur annually (150 million in 
developing nations), causing nearly 2 million deaths in children <5 years, making 
pneumonia the most common cause of mortality among young children worldwide.1 
Previous reports have noted a high pneumonia incidence in Southeast asia,1 although few 
country-specific estimates exist. A 2008 Bulletin of the World Health OrGAnization (WHO) 
concluded that “a comprehensive and accurate description of the epidemiology and 
etiology” of childhood pneumonia is an essential first step for the prevention and 
management of disease.2
The International Emerging Infections Program at the Global Disease Detection Center, part 
of a collaboration between the Thailand Ministry of Public Health (MoPH) and United 
States Centers for Disease Control and Prevention (CDC), has conducted surveillance for 
acute lower respiratory tract infection (ALRI) in 2 rural provinces in Thailand since 2003. 
Data collected for over 140,000 ALRI hospitalizations include demographics, clinical 
characteristics, chest radiograph (CXR) results and, for a large subset of patients, etiologic 
data. In this article, we present a comprehensive summary of our data on the incidence, 
clinical characteristics, seasonal trends and etiology of hospitalized ALRI in children <5 
years in rural Thailand.
METHODS
Population
Thailand is a middle-income nation with a population of 4.36 million children <5 years old 
and a low infant mortality rate (8 deaths/1000 live births).3 Basic health care services at 
public facilities are free or available for a nominal fee. From 2006 to 2010, UNICEF 
estimated that 84% of children <5 years old with suspected pneumonia were taken to a 
health care provider. Neither pneumococcal conjuGAte vaccine nor Haemophilus influenzae 
type b (Hib) conjuGAte vaccine is part of Thailand’s expanded Program on immunization. 
Although both vaccines are available on the private market, coverage among children <5 
years old in the provinces under surveillance is <2% (unpublished data).
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Active, population-based surveillance for hospitalized ALRI cases beGAn in Sa Kaeo 
Province (eastern Thailand, bordering Cambodia; population 549,844 persons; 32,960 <5 
years of age) in 2002 and was expanded to Nakhon Phanom Province (northeastern 
Thailand, bordering laos; population 751,251 persons; 48,064 <5 years of age) in 2003.4 
These 2 provinces account for approximately 2% of Thailand’s population.
Surveillance was conducted at all district (16) and military (2) hospitals (10–140 inpatient 
beds) and at both provincial hospitals (225 and 327 inpatient beds), which represent all acute 
care hospitals in these provinces; there are no private hospitals. ALRI surveillance methods 
have been described in detail elsewhere.5–7 in brief, surveillance officers reviewed 
admission logbooks daily to identify patients with diagnoses related to possible respiratory 
illness for further data collection. Newborns hospitalized since birth were excluded.
ALRI was defined as evidence of acute infection (reported fever, documented temperature 
>38.0%C, elevated age-specific white blood cell count or abnormal differential) and 
symptoms/ signs of respiratory illness (abnormal breath sounds, tachypnea based on 
documented respiratory rate, cough, sputum production, hemoptysis, chest pain or dyspnea) 
at the time of admission. Previous reports from these surveillance sites have used this case 
definition.7–10 CXRs were performed at clinician discretion. If done, CXrs were digitized 
and interpreted by 3 radiologists using standardized criteria.11 A patient was considered to 
have radiographically confirmed pneumonia if 2 of 3 independent radiologists interpreted 
the CXR as consistent with probable or definite pneumonia.
Etiology Evaluation
A systematic sample of ALRI patients was selected for possible enrollment in an etiology 
study. Between 2005 and 2007, eligibility was limited to ALRI patients for whom a CXR 
was performed within 48 hours of hospital admission (reGArdless of results). Beginning in 
January 2008, every other patient with ALRI was considered eligible (ie, 50% sample), 
whether a CXR was performed. Participants provided nasopharyngeal (NP) swab specimens 
and, during 2005, paired serum specimens (at enrollment and 3–5 weeks later). NP swab 
specimens were collected from all participants, using polyester swabs (Puritan, guilford, 
ME) from 2005 to June 2010 and using flocked swabs (FLOQSwabs, Copan, Murrieta, CA) 
since July 2010. NP specimens were inoculated in viral transport media, stored at 4–8°C for 
up to 24 hours before being frozen at −70°C and transported weekly on dry ice to Bangkok. 
This study was approved by a CDC Institutional Review Board (Protocol 3754) and the 
ethical review Committee of the Thailand MoPH. Guardians provided written consent for 
their child’s participation.
From January 2005 to December 2007, we tested NP swab specimens from a convenience 
sample of controls: outpatients without fever, cough, sore throat or diarrhea within the 
previous 3 days. Controls were enrolled in the outpatient departments of the 2 provincial 
hospitals.
Specimens were tested at the uS CDC, Atlanta, GA, through mid-2005 with all subsequent 
testing at the Thailand National Institute of Health. Laboratory methods have been described 
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previously.10 in brief, testing for viruses was performed using a combination of conventional 
(first 6 months of 2005) and real-time (last 6 months of 2005 through 2010) reverse-
transcription polymerase chain reaction (PCR), serology and viral culture. rhinoviruses and 
coronaviruses were tested only in 2005.8,12 Serology and viral culture were performed 
during 2005 only. Infections were determined by a positive PCR or culture or a 4-fold rise in 
antibody titer. Specimens from controls were tested only for viruses by PCR.
Blood cultures were collected at clinician discretion, processed using the Bact/alert 3d 
System (bioMeriéux) and subcultured using standard methods.9,13 We sought to collect 4 ml 
of blood for culture, but a previous analysis found that only 45% of children with blood 
culture performed had 4 ml collected and 27.7% had <2 ml.14
Statistical Analysis
Analyses were conducted in Stata, version 9.1 (StataCorp lP, College Station, tX). to 
minimize double counting the same ALRI episode, readmissions within 14 days of a 
previous hospital discharge and referrals/transfers from other hospitals in the same province 
(n = 1109) were excluded from all incidence calculations; however, data from these 1109 
admissions and referrals were used for etiologic findings and patient outcomes.
Confidence intervals (CI) for incidence rates (IRs) were calculated using the standard 
formula for counts, while Cis for incidence rate ratios (IRRs) were calculated using exact 
methods. An adjusted number of CXR-confirmed cases was estimated by applying the 
proportion of CXRs with evidence of pneumonia among those with interpretations to the 
total number of cases with CXRs performed.
RESULTS
During 2005–2010, 28,543 ALRI hospitalizations occurred among children <5 years of age. 
Forty-nine percent (n = 14,047) had a CXR performed. Of those, 10,484 (75%) had a final 
radiologist reading, of which 6645 (63%) had radiographic evidence of pneumonia. More 
than one-third (37%) of abnormal CXRs had a nonconsolidated alveolar infiltrate, 10.4% 
showed a consolidation and two-thirds showed an interstitial infiltrate (Table 1). Ninety-
three percent met the definition for severe acute respiratory infection, as defined by the 
WHO.15 Males accounted for 59.0% of ALRI cases (n = 16,846), which was similar when 
stratifying by age and province. Overall, 1.1% (n = 317) required intubation, 22% (n = 
6407) received supplemental oxygen and 9% (n = 520) had recorded oxygen saturation 
<90% on admission. Ninety-eight hospitalized ALRI case-patients died (0.3%, population 
mortality rate 19.0 per 100,000 person-years); these deaths were most common among the 
youngest cases, those with bacteremia and those who were intubated (Table 1). Death 
occurred in 0.8% of those with radiographically confirmed pneumonia compared with 0.2% 
of those without radiographically confirmed pneumonia (P < 0.01). Among cases with 
CXRs obtained and with evidence of alveolar consolidation, death occurred in 2.9%. Fifty-
eight patients were known to be HiV positive.
CXRs were obtained more often for patients who were intubated or who died in hospital 
(86% and 80% of those who were intubated or died had CXRs vs. 49% and 50% of those 
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who were not intubated or did not die, respectively). Nasopharyngeal swab collection was 
less common among intubated or fatal ALRI cases (19%) compared with nonintubated, 
nonfatal cases (26%).
Neonates (<28 days old, median age 15 days) comprised 0.7% (n = 195) of hospitalized 
ALRI cases. Compared with children in other age groups, neonates were less likely to have 
cough (53% vs. 97%) and more likely to have chest indrawing (25% vs. 6–12%) (Table 1). 
A lower proportion of neonates had radiographically confirmed pneumonia compared with 
the older age categories although a larger proportion required mechanical ventilation.
Incidence
The IR of ALRI receiving hospitalization among children <5 years old was 5772 cases per 
100,000 person-years (Table 2). Compared with patients <6 months of age, those 6–23 
months of age had a higher IR (IRR 1.76, 95% Ci: 1.69–1.84), whereas the irr for those 24–
59 months of age was 0.69 (95% Ci: 0.66–0.72). incidence was nearly 40% higher among 
boys than girls (IRR 1.38, 95% CI: 1.35–1.41); this relationship remained after stratification 
by province and age. the IR of radiographically confirmed pneumonia was 1800 cases per 
100,000 personyears (95% Ci: 1774–1827); comparisons by sex, age and province followed 
similar patterns as those observed for hospitalized ALRI cases overall (Table 2). the ir of 
ALRI among neonates <28 days old was 2897 per 100,000 person-years (95% Ci: 2520–
3274). Table, Supplemental Digital Content 1, http://links. lww.com/INF/B816, shows 
incidence of both ALRI and radiographically confirmed ALRI hospitalizations by month of 
age.
Seasonal Trends
For all age categories, we observed 2 annual seasonal ALRI elevations in hospitalized 
ALRI: an increase from February to March (IRR 1.48, 95% CI: 1.39–1.58) and a larger 
increase from June through October (IRR 1.76, 95% CI: 1.65–1.86), both measures 
compared with incidence during nonpeak months (april, May, november, december and 
January) (Fig. 1). The 2 peaks were similarly sized in children <6 months; however, the June 
to October peak was significantly larger compared with the February to March peak among 
children >6 months (data not shown).
Etiology
Virus testing was performed for 7388 (25.6%) ALRI patients (Table 3). Other than 
rhinoviruses and bocavirus, the most commonly identified pathogens were respiratory 
syncytial virus (RSV) (n = 1430, 19.5%) and influenza viruses (n = 602, 8.4%). The 
proportion with rSV was highest in children <6 months of age and decreased with increasing 
age, while the proportion with influenza viruses increased with age. In patients with mixed 
viral Infections (n = 237), the most common combinations were RSV with influenza a (n = 
46) and RSV with rhinovirus (n = 42). We did not find substantial differences in CXR 
pattern by type of viral infection. Of 20 neonates tested, 8 had viruses detected, including 
RSV (n = 3), RSV/human parainfluenza virus (HPiV) 2 coinfection (n = 1), rhinovirus (n = 
2), influenza B (n = 1) and adenovirus (n = 1).
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RSV Infections occurred most frequently during June to October (87% of all RSV cases), 
coinciding with the large peak in ALRI. Influenza a and B viruses displayed 2 peaks: one 
during February to March and the other during June to October.
During 2005–2007, 667 controls <5 years of age were enrolled with a mean age of 1.7 years; 
22% were <6 months, 31% were 6–23 months and 47% 24–59 months. ALRI cases were 
significantly more likely to test positive for RSV, influenza A and B viruses, adenovirus, 
HPIV 1 and 3 and human metapneumovirus (HMPV), but not for rhinoviruses or 
coronaviruses39 (Table 4).
Blood cultures were collected from 28% (n = 7975) of all ALRI patients hospitalized from 
2005 to 2010, with the younger age groups more likely to have blood cultures collected 
(35% of children <6 months) (Table 5). Overall, 88.8% (n = 7082) of cultures were 
neGAtive and 1.8% (n = 145) were positive for a bacterial pathogen. Nontyphoidal 
Salmonella, Streptococcus pneumoniae and Haemophilus influenzae were the most 
commonly identified pathogens. Likely contaminants were isolated in 8.1% (n = 649). Fifty-
two percent (n = 101) of neonates <28 days of age had blood cultures and 2 were positive: 
one for Staphylococcus aureus and the other for Mycobacterium tuberculosis complex (later 
confirmed as Mycobacterium bovis Bacille Calmette-guérin).16
Among children with CXR-confirmed pneumonia and blood cultures collected, pathogen 
detection was more common among those with alveolar consolidation [9/312 (2.9%)] 
compared with those with other infiltrates [25/1827 (1.4%)] (P < 0.05).
DISCUSSION
We found a high incidence of hospitalized ALRI in thai children <5 years of age (5772 cases 
per 100,000 person-years) with higher rates among boys, among children 6–23 months of 
age and during June through October. Complicated illness requiring intubation affected ~1% 
of cases overall but was more common among neonates (17%) and infants 28 days to <6 
months old (5%). RSV was the most common viral pathogen associated with ALRI, 
followed by influenza, while the most common bacterial pathogens were nontyphoidal 
Salmonella, S. pneumoniae and H. influenzae. Only 1.8% of cases with blood culture had 
confirmed bacteremia.
Our estimates were similar to minimum estimates of hospitalized pneumonia incidence in a 
systematic review in China (6000 cases per 100,000 person-years)17 and somewhat higher 
than estimates from taiwan (3965–4984 per 100,000 person-years)18 and Bangladesh (5020 
per 100,000 person-years).19 The Bangladeshi study was most similar to ours, in that it 
incorporated active surveillance methods in 7 hospitals. Our incidence estimates were twice 
as high as estimates from the Child Health Epidemiology Reference Group, which estimated 
the incidence of severe and very severe ALRI hospitalizations among children <5 years of 
age in developing countries to be 19.7 and 5.1 cases per 1000 child-years, respectively.20 
Analyzing data from published studies, Child Health Epidemiology Reference Group 
estimated that the incidence of severe ALRI in Southeast asia to be 17.8 cases per 1000 
child-years.
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Our IRs may have been influenced by active case finding and a lower threshold for 
hospitalization in the setting of very good health care access,21 thereby elevating IRs and 
lowering the proportion of those with severe disease and poor outcome. Furthermore, our 
sensitive ALRI case definition captured a broader group of cases than only those with 
pneumonia. Only 23% of ALRI cases had elevated respiratory rates compared with the age-
specific norms used for the WHO definition of nonsevere pneumonia,22 although our data 
collection procedures were not standardized for this sign.
However, it is worth noting that 93% of our ALRI cases met the WHO case definition for 
severe acute respiratory infection.15 We prioritized a sensitive case definition to improve 
capture of cases with respiratory pathogens; for example, 67% of 1430 RSV-associated and 
77% of 602 influenza virus-associated hospitalizations would have been missed if we had 
used WHO case definitions of pneumonia (severe or nonsevere). By contrast, our definition 
of CXR-confirmed pneumonia based on standardized readings from 3 radiologists was more 
specific and thereby provided a minimum (yet still substantial) IR of hospitalized ALRI in 
rural Thailand.
Our estimates are also 3.5 times higher than those reported by the Thailand MoPH (1580 
cases per 100,000 person-years in children <5 years in 2010),23 which relies on passive 
reporting based on clinician diagnosis. CXR-confirmed pneumonia IRs in our analysis are 
similar to the MoPH’s overall rate, suggesting that Thai clinicians may base reporting of 
pneumonia cases on CXR data.
Our finding of higher ALRI IRs in boys is consistent with previous studies.18–20,24,25 
Cultural traditions in Thailand do not display a male preference, so this difference is 
unlikely related to increased health care–seeking behavior for sons.21 There is some 
evidence that asthma is more prevalent among boys than girls in Thailand26 and the united 
States.27,28 Although many factors may have a role, it is possible that despite equal exposure 
to respiratory pathogens, boys are more likely to develop Infections that warrant 
hospitalization due to their higher prevalence of underlying asthma. Additional 
investiGAtion into higher ALRI rates among boys is needed.
Despite a lack of empiric data, pneumonia burden among neonates is believed to be 
substantial.1 Neonatal ALRI is difficult to study due to variable illness presentation, clinical 
overlap with sepsis and other neonatal conditions and the challenges of obtaining adequate 
samples for etiology studies.29 We estimated a neonatal ALRI IR of 2897 cases per 100,000 
person-years, 70% lower than the rate among those 6–23 months of age. Although this 
estimate is subject to the aforementioned limitations, our standardized data collection over 6 
years offers insight into neonatal disease burden, symptomatology, outcomes and pathogen 
distribution.
Similar to our previously published work, we found a consistent seasonal peak of 
hospitalized ALRI in February to March and a larger peak during June to October.6,7,10 
Influenza and parainfluenza viruses contributed prominently to both peaks of ALRI 
incidence, whereas RSV displayed only 1 large June to October elevation. understanding 
ALRI seasonal patterns is essential for effective resource allocation and planning of 
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preventive and therapeutic interventions, including the distribution of vaccines, medications 
and personnel. Consistent timing of annual RSV peaks supports the feasibility of 
interventions that are best timed with seasonal epidemics, such as palivizumab for high-risk 
infants30 or possibly, in the future, vaccines.
We found that a high proportion of ALRI hospital admissions had the detection of bocavirus 
or rhinoviruses, but the etiologic contribution of these viruses remains uncertain. Bocavirus 
infection was previously shown to be more common among hospitalized ALRI cases in Sa 
Kaeo Province than among controls although 91% of bocavirus-positive ALRI patients <5 
years of age were coinfected with another virus.31 Rhinovirus infection in the current 
analysis was not significantly more common among cases than among controls, but 
differences approached statistical significance and were consistent with previously published 
work from our sites that did show a significant association between hospitalized ALRI and 
rhinovirus detection.8 These data highlight the challenges of etiologic attribution with 
increasingly sensitive diagnostic assays for an increasing number of potential pathogens and 
underscore the value of testing controls without respiratory illness to assess causality. 
However, lack of association between ALRI and pathogen prevalence cannot definitively 
exclude the possibility that a pathogen is part of the causal pathway for disease. Our control 
design may not have been optimal to evaluate causality for all pathogens as we could not 
evaluate prolonged shedding from prior infection or shedding prior to the onset of 
symptoms. In addition to RSV, influenza a and B viruses, HMPV and HPIV1 and 3, we 
found that hospitalized ALRI was significantly associated with the detection of adenovirus, 
which differed from previous studies in Alaska (United States)33 and Kenya.34
Our data underestimate the bacterial contribution to childhood ALRI. We did not perform 
testing for Mycoplasma pneumoniae and Chlamydia pneumoniae during the analysis period, 
but a previous report from these sites found that only ~1% of ALRI cases among children <5 
years of age were positive for each.10 testing for tuberculosis was not done, and testing for 
other bacterial pathogens associated with severe pneumonia, such as S. pneumoniae and 
Haemophilus influenzae, was limited to blood culture. The sensitivity of blood cultures is 
low, and low blood volumes and prior antibiotic administration (~25%) likely limited the 
yield further.14 The relative frequency of nontyphoidal Salmonella (n = 21) and Escherichia 
coli (n = 13) was unexpected; enteric Gram-neGAtive bacteria are generally easier to isolate 
than Grampositives like S. pneumoniae and may have been less affected by antibiotic 
Pretreatment. Previous studies have identified invasive Salmonella infection among children 
with pneumonia, including a study from Thailand that identified cases with radiographic 
evidence of pulmonary infiltrates.35,36 Even under ideal testing conditions, only a fraction of 
bacterial pneumonia cases are bacteremic. Based on a pneumococcal conjuGAte vaccine 
probe study in South africa, only 3.4% of pneumococcal clinical pneumonia cases had 
positive blood cultures.37
Our conclusions were limited by surveillance that only captured ALRI cases requiring 
hospitalization, which missed the substantial outpatient burden and biased descriptions of 
seasonality and pathogen distribution toward cases severe enough to need hospitalization. 
Through community surveys, we believe that hospital-based surveillance captures 58–80% 
of all ALRI in these 2 provinces.21,38 Our findings provide informative data for rural 
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Thailand, but it is not clear that results can be generalized to more urban settings or other 
nations.
This analysis demonstrates a high incidence of hospitalized ALRI among young children in 
Thailand and suggests that important differences in IR exist by age, sex and season. Virus 
Infections account for the largest proportion of known pathogens, but a substantial 
proportion remain of unknown etiology. Our results underscore the critical need for effective 
prevention and control measures for high-burden pathogens such as RSV, highlight the 
potential impact of proven prevention measures (eg, influenza and pneumococcal conjuGAte 
vaccines) and emphasize the need for continued efforts to better define ALRI etiology, 
including the need for improved molecular-based diagnostic approaches in young children.
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TABLE 2
Incidence Rate (Per 100,000 Person-Years) of ALRI and Radiographically Confirmed Pneumonia, Stratified 
by Province, Sex and Age, in Hospitalized Children <5 years, Sa Kaeo and Nakhon Phanom Provinces, 
Thailand, 2005–2010
ALRI (n = 28,543) Radiographically Confirmed* (n = 6645)
IR 95% CI IRR 95% CI IR 95% CI IRR 95% CI
Overall 5772 5707–5837 1800 1774–1827
Girls 4833 4748–4919 1.0 1492 1458–1525 1.0
Boys 6671 6574–6769 1.38 1.35–1.41 2096 2056–2136 1.41 1.34–1.48
<6 months 5561 5352–5770 1.0 2059 1963–2155 1.0
6–23 months 9795 9643–9947 1.76 1.69–1.84 3230 3168–3293 1.57 1.45–1.7
24–59 months 3848 3779–3916 0.69 0.66–0.72 1064 1038–1091 0.52 0.48–0.56
Sa Kaeo 5303 5204–5401 1.0 1664 1626–1701 1.0
Nakhon Phanom 6086 6000–6172 1.15 1.12–1.18 1888 1852–1924 1.13 1.08–1.19
2005 5716 5563–5869 1.0 1720 1660–1779 1.0
2006 5609 5453–5765 0.98 0.94–1.02 1705 1643–1766 0.99 0.91–1.08
2007 5590 5432–5748 0.98 0.94–1.02 1683 1615–1751 0.98 0.9–1.07
2008 5943 5779–6106 1.04 1–1.08 1875 1815–1936 1.09 1.01–1.18
2009 5091 4939–5243 0.89 0.85–0.93 1506 1446–1565 0.88 0.8–0.95
2010 6691 6519–6863 1.17 1.13–1.22 2327 2251–2403 1.35 1.25–1.46
*
Applying proportion of CXRs with evidence of pneumonia to the total number of CXRs performed.
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TABLE 4
Viral Testing Results Among Hospitalized ALRI Cases and Outpatient Controls* With Age-Adjusted Odds 
Ratios (AOR) and 95% CI, 2005–2007
ALRI Cases (n = 3845) Controls (n = 667)
n/Tested % n/Tested % AOR 95% CI
RSV 776/3809 20.4 7/589 1.2 21.3 10.1–45.1
Influenza A 227/3809 6.0 3/589 0.5 12.4 3.9–38.9
Influenza B 71/3809 1.9 2/589 0.3 5.3 1.3–21.9
Adenovirus 128/3809 3.4 5/589 0.8 3.4 1.4–8.5
HPIV 1 119/3809 3.1 2/589 0.3 8.9 2.2–36.3
HPIV 2 30/3809 0.8 1/589 0.2 4.7 0.6–34.7
HPIV 3 198/3809 5.2 1/589 0.2 29.8 4.2–213
HMPV 111/3809 2.9 1/658 0.2 19.5 2.7–140
Rhinoviruses 169/903 18.7 14/116 12.1 1.6 0.9–2.9
*
Case–control comparisons for bocavirus and coronavirus were previously published; bocavirus detection was significantly more common among 
ALRI cases than among controls,31 while coronavirus detection was not associated with case status.39
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